Short answer
SBC Medical Group Holdings Inc (SBC) filed its Q3 2025 10-Q quarterly report on Nov 14, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $43M (down 73.1% year over year) with net income of $13M.
Q3 2025 key financials · XBRL
- Revenue
- $43M
- −73.1% YoY · −0.0% QoQ
- Net income
- $13M
- −68.5% YoY · +421.7% QoQ
- Operating margin
- 36.6%
- Gross margin
- 70.6%
- EPS (diluted)
- $0.13
- −69.0% YoY · +550.0% QoQ
Source: XBRL data from the SBC Medical Group Holdings Inc (SBC) Q3 2025 10-Q on SEC EDGAR. USD.
SBC Medical Group Holdings Inc Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- No profitability or margin figures reported for the quarter
- No cash position, operating cash flow, or capital deployment updates mentioned
- Management highlights emerging growth company and smaller reporting company status with related regulatory exemptions, no updated guidance or outlook
Risk Factors
- New risk: Business Combination with Pono Capital Two, Inc. on Sept 17, 2024, adds integration and public company compliance risks
- Material update: Fee structure revision for clinic services effective April 1, 2025 causes 21.51%-36.71% franchising revenue decline
- Regulatory risk: Japanese Medical Care Act limits SBC's voting control despite equity interests in six franchisee medical corporations
- Operational risk: Discontinuation of clinic operation staff services from Jan 2025 reduces management services revenue by 47.54% YTD
- Financial risk: Negative operating cash flow of $(27.3)M for nine months ended Sept 30, 2025, despite $36.8M net income reported
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other SBC Medical Group Holdings Inc quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.